HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $627,040 | +11.1% | 5,420 | -1.2% | 0.00% | 0.0% |
| Q2 2023 | $564,441 | +18.3% | 5,488 | +25.5% | 0.00% | 0.0% |
| Q1 2023 | $477,160 | -94.8% | 4,372 | -94.6% | 0.00% | -93.9% |
| Q4 2022 | $9,244,316 | -63.3% | 81,233 | -80.0% | 0.03% | -34.0% |
| Q3 2022 | $25,186,377 | -60.2% | 406,960 | -48.7% | 0.05% | -57.3% |
| Q2 2022 | $63,214,771 | -33.4% | 792,572 | -12.2% | 0.12% | -13.3% |
| Q1 2022 | $94,958,590 | +72.9% | 902,568 | +77.1% | 0.14% | -3.6% |
| Q4 2021 | $54,908,000 | -14.9% | 509,538 | -13.5% | 0.14% | -22.7% |
| Q3 2021 | $64,557,000 | -48.8% | 589,349 | -56.2% | 0.18% | 0.0% |
| Q2 2021 | $126,096,000 | +125.0% | 1,346,600 | +121.2% | 0.18% | +5.8% |
| Q1 2021 | $56,041,000 | +25.5% | 608,875 | -0.3% | 0.17% | +22.1% |
| Q4 2020 | $44,661,000 | +19.2% | 610,539 | +26.6% | 0.14% | +3.7% |
| Q3 2020 | $37,468,000 | -37.9% | 482,336 | -55.6% | 0.14% | +13.4% |
| Q2 2020 | $60,320,000 | +154.8% | 1,085,278 | +35.8% | 0.12% | +101.7% |
| Q1 2020 | $23,674,000 | +33.4% | 799,276 | +63.1% | 0.06% | +63.9% |
| Q4 2019 | $17,742,000 | +35.6% | 490,094 | +2.0% | 0.04% | +38.5% |
| Q3 2019 | $13,082,000 | +9.2% | 480,428 | -3.5% | 0.03% | +13.0% |
| Q2 2019 | $11,984,000 | – | 498,066 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |